Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Submitted by
admin
on April 6, 2015 - 11:46am
Source:
Fierce Pharma
News Tags:
JNJ
M&A
Pharmacyclics
AbbVie
Alex Gorsky
Headline:
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Do Not Allow Advertisers to Use My Personal information
